Basilea Pharmaceutica (BPMUF) Ownership Overview
3.56% Mutual Funds
0.11% Other Institutional Investors
12.38% ETFs
83.95% Public Companies and
Individual Investors
The ownership structure of Basilea Pharmaceutica (BPMUF) stock is a mix of institutional, retail, and individual investors. Approximately 16.05% of the company’s stock is owned by Institutional Investors, and 83.95% is owned by Public Companies and Individual Investors.
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 547,944 | Institution | 4.08% | 42,451,961 | |
| 378,755 | Institution | 2.82% | 29,344,044 | |
| 321,579 | Institution | 2.39% | 24,914,333 | |
| 249,346 | Institution | 1.86% | 19,318,081 | |
| 177,071 | Institution | 1.32% | 13,718,576 | |
| 118,139 | Institution | 0.88% | 9,152,819 | |
| 83,987 | Institution | 0.62% | 6,506,893 | |
| 60,866 | Institution | 0.45% | 4,715,593 | |
| 51,387 | Institution | 0.38% | 3,981,208 | |
| 47,943 | Institution | 0.36% | 3,714,384 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 177,071 | Institution | 1.32% | 13,718,576 | |
| 118,139 | Institution | 0.88% | 9,152,819 | |
| 83,987 | Institution | 0.62% | 6,506,893 | |
| 47,943 | Institution | 0.36% | 3,714,384 | |
| 23,153 | Institution | 0.17% | 1,793,779 | |
| 10,782 | Institution | 0.08% | 835,335 | |
| 8,333 | Institution | 0.06% | 645,599 | |
| 3,606 | Institution | 0.03% | 279,375 | |
| 3,312 | Institution | 0.02% | 256,597 | |
| 2,155 | Institution | 0.02% | 166,959 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 534 | Institution | <0.01% | 42,252 |
FAQ
Who Owns Basilea Pharmaceutica (BPMUF)?
Currently, no data Available
What percentage of Basilea Pharmaceutica (BPMUF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.11% of Basilea Pharmaceutica (BPMUF) stock is held by institutional investors.
What percentage of Basilea Pharmaceutica (BPMUF) stock is held by retail investors?
According to the latest TipRanks data, approximately 83.95% of Basilea Pharmaceutica (BPMUF) stock is held by retail investors.
Who owns the most shares of Basilea Pharmaceutica (BPMUF)?
Xtrackers owns the most shares of Basilea Pharmaceutica (BPMUF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.